Optimizing Thermal Ablation with Ron Murphy of Theromics

What are the limitations of thermal ablation and how could this procedure be improved upon?

Thermal ablation is a minimally invasive, image-guided treatment that uses heat or extreme cold to destroy tumor cells, including cancer and sometimes to treat benign tumors. However, up to 30% of localized lesions recur due to 3 factors:

1) Incomplete ablation at margins caused by “Heat Sinks”

2) Insufficient thermal energy penetration

3) Tissue targeting inaccuracy

In this episode, we chat with Ron Murphy, CEO of Theromics, to discuss how they are developing a next-generation thermal accelerant technology for soft tissue ablation procedures and combination therapy. With multiple applications, this exciting innovation could help to alleviate the current issues and lead to superior patient outcomes.

Ron shares how they plan to take this solution to market, the challenges that need to be navigated, and provides a range of insights that every entrepreneur could benefit from.